Funder
University of Oxford
Wellcome Trust
University Hospitals Harrington Discovery Institute
NIHR BioResource
Vascular Cures
Reference40 articles.
1. Glycolate oxidase is a safe and efficient target for substrate reduction therapy in a mouse model of primary hyperoxaluria Type I;Martin-Higueras;Mol. Ther.,2016
2. Primary hyperoxaluria;Pierre;N. Engl. J. Med.,2013
3. Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1;Garrelfs;N. Engl. J. Med.,2021
4. Triazole Glycolate Oxidase Inhibitors;Maag,2020
5. Glycolate oxidase inhibitors for the treatment of disease;Wang;US Patent and Trademark Office, US20230089374A1,2023